Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alterity, Arrowhead, Bioarctic, Eisai, Geovax Labs, H. Lundbeck, Innocare, Lynk, Otsuka, Pardes, Takeda.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Arrowhead, Beactica, Dr. Reddy’s, Eagle, Evopoint, JCR, Karveer Meditech, Merck, Nanoviricides, Oscotec, Sumitomo, Takeda, Tonix.

Biopharmas in Asia-Pacific raising money in public or private financings: Cocrystal, Psyence, Recce.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Moximed, R2 Technologies, Reach Neuro.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Artera, Advanced Cooling, Attune Medical, Bone Biologics, Bristol Myers Squibb, Dermtech, Discovery Life Sciences, Foundation Medicine, Glooko, Hedia, Illumina, IMA Group, Neovasc, Reachbio Research, Shockwave Medical.

Med-tech firms raising money in public or private financings, including: Oshi Health, Sentiar.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Can-Fite, JW, Merck, Moderna, Promis, Sumitomo.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptimmune, Astrazeneca, BMS, Foundation Med., Fulgent Genetics, GSK, Imagine, Lygenesis, Mission, Novartis, One-Two, Panbela, Pharming, Provention, Quince, Sanofi, Sobi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABVC, Altamira, Durect, Eisai, Evecxia, Horizon, Mabwell, Merck, Molecular Templates, Nuance, Nuvectis.

Biopharmas raising money in public or private financings, including: 180 Life Sciences, Annovis, Ctrl, Mosanna, Mydecine, Oncosec.